Search - Archive ouverte HAL Access content directly

Filter your results

258 Results
Structure: Internal structure identifier : 28519

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

Nicolas Jacquelot , Takahiro Yamazaki , Maria Roberti , Connie Duong , Miles Andrews et al.
Cell Research, 2019, 29 (10), pp.846-861. ⟨10.1038/s41422-019-0224-x⟩
Journal articles hal-02461559v1
Image document

Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Jean-Baptiste Fraison , Arsène Mekinian , Eric Grignano , Jean-Emmanuel Kahn , Jean-Benoit Arlet et al.
Leukemia Research, 2016, 43, pp.13-17. ⟨10.1016/j.leukres.2016.02.005⟩
Journal articles hal-01278608v1

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance

Michaël Cerezo , Abdelali Lehraiki , Antoine Millet , Florian Rouaud , Magali Plaisant et al.
Cancer Cell, 2016, 29 (6), ⟨10.1016/j.ccell.2016.04.013⟩
Journal articles hal-01357448v1

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Bertrand Routy , Emmanuelle Le Chatelier , Lisa Derosa , Connie Duong , Maryam Tidjani Alou et al.
Science, 2018, 359 (6371), pp.91-97. ⟨10.1126/science.aan3706⟩
Journal articles hal-02126484v1

Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes

Pierre Bigot , Jean-François Hétet , Jean-Christophe Bernhard , Tarek Fardoun , François Audenet et al.
Clinical Genitourinary Cancer, 2014, 12 (1), pp.e19--27. ⟨10.1016/j.clgc.2013.09.004⟩
Journal articles hal-01064296v1

Enhanced cytotoxic activity of ex vivo-differentiated human natural killer cells in the presence of HOXB4.

Arash Nanbakhsh , Cécile Pochon , Sophie Amsellem , Gianfranco Pittari , Ania Tejchman et al.
Journal of Immunotherapy, 2014, 37 (5), pp.278-282
Journal articles hal-01179538v1

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.

François Ghiringhelli , Lionel Apetoh , Antoine Tesniere , Laetitia Aymeric , Yuting Ma et al.
Nature Medicine, 2009, epub ahead of print. ⟨10.1038/nm.2028⟩
Journal articles hal-00419823v1
Image document

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).

Astrid Lièvre , Anthony Turpin , Isabelle Ray-Coquard , Karine Le Malicot , Juliette Thariat et al.
European Journal of Cancer, 2020, 141, pp.62-81. ⟨10.1016/j.ejca.2020.09.035⟩
Journal articles hal-02998283v1

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu , Takahiro Yamazaki , Erika Vacchelli , Kariman Chaba , David Enot et al.
Nature Medicine, 2014, 20 (11), pp.1301-1309. ⟨10.1038/nm.3708⟩
Journal articles hal-02047408v1
Image document

Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)

Emmanuelle Samalin , Christelle de La Fouchardière , Simon Thèzenas , Valérie Boige , Hélène Senellart et al.
Clinical Colorectal Cancer, 2020, ⟨10.1016/j.clcc.2020.04.008⟩
Journal articles hal-02912931v1

Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring

Sotheara Moeung , Christine Chevreau , Vianney Poinsignon , Jérôme Guitton , Bénédicte Lelièvre et al.
Therapeutic Drug Monitoring, 2019, 41 (1), pp.66-74. ⟨10.1097/FTD.0000000000000569⟩
Journal articles hal-02481351v1
Image document

Targeting genome integrity dysfunctions impedes metastatic potency in non–small cell lung cancer circulating tumor cell–derived explants

Tala Tayoun , Vincent Faugeroux , Marianne Oulhen , Olivier Déas , Judith Michels et al.
JCI Insight, 2022, 7, ⟨10.1172/jci.insight.155804⟩
Journal articles hal-03853591v1

Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe

Denis Horgan , Giuseppe Curigliano , Olaf Rieß , Paul Hofman , Reinhard Büttner et al.
Journal of Personalized Medicine, 2022, 12 (1), pp.72. ⟨10.3390/jpm12010072⟩
Journal articles hal-03857611v1
Image document

Cell clusters adopt a collective amoeboid mode of migration in confined nonadhesive environments

Diane-Laure Pagès , Emmanuel Dornier , Jean de Seze , Emilie Gontran , Ananyo Maitra et al.
Science Advances , 2022, 8 (39), eabp8416. ⟨10.1126/sciadv.abp8416⟩
Journal articles hal-03808168v1

Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome

Alice Mogenet , Fabrice Barlesi , Benjamin Besse , Stefan Michiels , Maryam Karimi et al.
Lung Cancer, 2022, 169, pp.31-39. ⟨10.1016/j.lungcan.2022.05.004⟩
Journal articles hal-03925563v1

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

P. Pautier , A. Floquet , C. Chevreau , N. Penel , C. Guillemet et al.
ESMO Open, 2021, 6 (4), pp.100209. ⟨10.1016/j.esmoop.2021.100209⟩
Journal articles hal-03623631v1

Adjuvant chemotherapy versus perioperative chemotherapy (CTx) for resectable gastric signet ring cell (SRC) gastric cancer: A multicenter, randomized phase II study (PRODIGE 19).

Clarisse Eveno , Antoine Adenis , Olivier Bouche , Karine Le Malicot , Vincent Hautefeuille et al.
Journal of Clinical Oncology, 2019, 37 (15, S), ⟨10.1200/JCO.2019.37.15\_suppl.4019⟩
Journal articles hal-03597236v1

Bamlanivimab + Etesevimab Therapy Induces SARS-CoV-2 Immune Escape Mutations and Secondary Clinical Deterioration in COVID-19 Patients with B-cell Malignancies

F. Pommeret , J. Colomba , C. Bigenwald , A. Laparra , S. Bockel et al.
Annals of Oncology, 2021, 32 (11), pp.1445--1447. ⟨10.1016/j.annonc.2021.07.015⟩
Journal articles hal-03793520v1

Comparative analysis of docetaxel: physical and chemical characterisation of Taxotère® and generics

Roy Pétronille , Do Bernard , Le Guyader Guillaume , Viellard Victoire , Fleury Thomas et al.
European Journal of Cancer, 2020, 135, pp.183-191. ⟨10.1016/j.ejca.2020.04.029⟩
Journal articles hal-03882651v1

Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study

Sandrine Monestier , Stéphane Dalle , Laurent Mortier , Caroline Dutriaux , Sophie Dalac-Rat et al.
International Journal of Cancer, 2021, 148 (11), pp.2789-2798. ⟨10.1002/ijc.33467⟩
Journal articles hal-03287366v1

Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS

Celine Callens , François Clément Bidard , Anaïs Curto-Taribo , Olfa Trabelsi-Grati , Samia Melaabi et al.
Analytical Chemistry, 2022, 94 (16), pp.6297-6303. ⟨10.1021/acs.analchem.2c00446⟩
Journal articles hal-03673620v1
Image document

Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma

Fanélie Jouenne , Isaure Chauvot de Beauchêne , Emeline Bollaert , Marie-Francoise Avril , Olivier Caron et al.
Journal of Medical Genetics, 2017, 54 (9), pp.607-612. ⟨10.1136/jmedgenet-2016-104402⟩
Journal articles hal-01580787v1

The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients

Pierre Rosenbaum , Cécile Artaud , Sylvie Bay , Christelle Ganneau , Mario Campone et al.
Cancer Immunology, Immunotherapy, 2020, 69 (5), pp.703-716. ⟨10.1007/s00262-020-02503-0⟩
Journal articles pasteur-03329313v1

Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group

Axel Le Cesne , Isabelle Ray-Coquard , Florence Duffaud , Christine Chevreau , Nicolas Penel et al.
European Journal of Cancer, 2015, 51 (6), pp.742-750. ⟨10.1016/j.ejca.2015.01.006⟩
Journal articles hal-03623749v1

Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

L. Kinget , E. Roussel , D. Lambrechts , B. Boeckx , A. T. L. Verbiest et al.
Annals of Oncology, 2021, 32, pp.S706-S706. ⟨10.1016/j.annonc.2021.08.085⟩
Journal articles hal-03440342v1
Image document

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

Gladys Ferrere , Maryam Tidjani Alou , Peng Liu , Anne-Gaëlle Goubet , Marine Fidelle et al.
JCI Insight, 2021, 6 (2), ⟨10.1172/jci⟩
Journal articles hal-03169306v1
Image document

The Use of Natural Agents to Counteract Telomere Shortening: Effects of a Multi-Component Extract of Astragalus mongholicus Bunge and Danazol

Isabelle Guinobert , Claude Blondeau , Bruno Colicchio , Noufissa Oudrhiri , Alain Dieterlen et al.
Biomedicines, 2020, 8 (2), pp.31. ⟨10.3390/biomedicines8020031⟩
Journal articles hal-02563670v1
Image document

An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells

Shensi Shen , Sara Faouzi , Amandine Bastide , Sylvain Martineau , Hélène Malka-Mahieu et al.
Nature Communications, 2019, 10 (1), ⟨10.1038/s41467-019-13360-6⟩
Journal articles hal-02418638v1
Image document

Metabolic features of cancer cells impact immunosurveillance

Adrien Joseph , Pan Juncheng , Michele Mondini , Nizar Labaied , Mauro Loi et al.
Journal for Immunotherapy of Cancer, 2021, 9 (6), pp.e002362. ⟨10.1136/jitc-2021-002362⟩
Journal articles hal-03272265v1

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Patricia Pautier , Anne Floquet , Christine Chevreau , Nicolas Penel , Cécile Guillemet et al.
Lancet Oncology, 2015, 16 (4), pp.457-464. ⟨10.1016/s1470-2045(15)70070-7⟩
Journal articles hal-03623745v1